Section on Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center, Boston, Massachusetts, USA.
Diabetes Technol Ther. 2022 Feb;24(2):136-139. doi: 10.1089/dia.2021.0258. Epub 2021 Oct 13.
The coronavirus disease 2019 (COVID-19) pandemic likely affected youth with type 1 diabetes (T1D). We used electronic health record-extracted data to compare continuous glucose monitoring (CGM) metrics during 1 year of the pandemic with those of the previous year. The sample comprised CGM users, aged 1 to <18 years, with T1D duration ≥6 months (age <6 years) or ≥1 year (age ≥6 years). The prepandemic sample comprised 641 youth (52% female, aged 12.3 ± 3.5, T1D duration 6.0 ± 3.5 years). The pandemic sample comprised 648 youth (52% female, age 13.3 ± 3.5, duration 6.7 ± 3.8 years), with care delivered primarily through telemedicine. Mean CGM glucose was 6.3 mg/dL lower during the pandemic (187.3 ± 35.6) versus prepandemic (193.6 ± 33.0) ( < 0.001). A higher percentage of youth achieved glucose management indicator <7% during the pandemic than the prior year ( < 0.001). Lower CGM glucose values were observed during the COVID-19 pandemic. Future studies are needed to assess how changes in health care delivery, including telemedicine, and lifestyle during this time may have supported this improvement.
2019 年冠状病毒病（COVID-19）大流行可能影响了 1 型糖尿病（T1D）的青年患者。我们使用电子健康记录提取的数据比较了大流行期间和前一年的连续血糖监测（CGM）指标。该样本包括 CGM 用户，年龄为 1 至 <18 岁，T1D 持续时间≥6 个月（年龄 <6 岁）或≥1 年（年龄≥6 岁）。大流行前的样本包括 641 名青年患者（52%为女性，年龄 12.3±3.5 岁，T1D 持续时间 6.0±3.5 年）。大流行期间的样本包括 648 名青年患者（52%为女性，年龄 13.3±3.5 岁，持续时间 6.7±3.8 年），主要通过远程医疗进行护理。与大流行前（193.6±33.0）相比，大流行期间的平均 CGM 血糖水平低 6.3mg/dL（187.3±35.6）（ < 0.001）。与前一年相比，大流行期间有更多的青年患者实现了血糖管理指标<7%（ < 0.001）。在 COVID-19 大流行期间观察到 CGM 血糖值降低。需要进一步研究评估在此期间医疗保健的变化，包括远程医疗，以及生活方式如何可能支持这一改善。
